Dec 17, 2019 My paper of the month - Consequences of increasing waiting times for treatment with commercially available autologous CAR-T cells targeting CD19 on the one-year all cause- survival for patients with relapsed/ refractory diffuse large B cell lymphoma.
Oct 29, 2019 My paper of the month - Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplantation in multiple myeloma
Oct 29, 2019 Clinical case of the month - Approach to Cytokine Release Syndrome and Neurotoxicity with CAR T-cell Therapy
Sep 30, 2019 My paper of the month - Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors
Mar 01, 2019 EBMT receives a regulatory qualification from the European Medicine Agency (EMA) on the use of its patient registry to support novel CAR T-cell therapies.
